Home LiteratureArticle Details
PMID: 16283513 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

Essential role of PI-3K, ERKs and calcium signal pathways in nickel-induced VEGF expression.

Molecular and cellular biochemistry ·Vol. 279 ·No. 1-2 ·2005-11-00 ·Pages 35-43

Ouyang W, Li J, Shi X, Costa M, Huang C

Abstract

Exposure to a highly nickel-polluted environment has the potential to cause a variety of adverse health effects, such as the respiratory tract cancers. Since numerous studies have demonstrated that nickel generally has weak mutagenic activity, research focus had turned to cell signalling activation leading to gene modulation and epigenetic changes as a plausible mechanism of carcinogenesis. Previous studies have revealed that nickel compounds can induce the expression of vascular endothelial growth factor (VEGF), which is a key mediator of angiogenesis both in physiological and pathologic conditions. In the present study, we investigated the potential roles of PI-3K, ERKs, p38 kinase and calcium signalling in VEGF induction by nickel in Cl 41 cells. Exposure of Cl 41 cells to nickel compounds led to VEGF induction in both time- and dose-dependent manners. Pre-treatment of Cl 41 cells with PI-3K inhibitor, wortmannin or Ly294002, resulted in a striking inhibition of VEGF induction by nickel compounds, implicating the role of PI-3K in the induction. However, mTOR, one of downstream molecules of PI-3K, may not contribute to the induction because pre-treatment of Cl 41 cells with its inhibitor, rapamycin, did not show obvious decrease in nickel-induced VEGF expression. Furthermore, pre-treatment of Cl 41 cells with MEK1/2-ERKs pathway inhibitor, PD98059, significantly inhibited VEGF induction by both NiCl2 and Ni3S2, whereas p38 kinase inhibitor, SB202190, did not impair the induction. Pre-treatment of Cl 41 cells with intracellular calcium chelator, but not calcium channel blocker, inhibited VEGF induction by nickel. Collectively these data demonstrate that PI-3K, ERKs and cytosolic calcium, but not p38 kinase, play essential roles in VEGF induction by nickel compounds.

MeSH Terms
Animals Calcium Signaling Cell Line Chelating Agents Chromones Dose-Response Relationship, Drug Egtazic Acid/analogs & derivatives Enzyme Activation Enzyme Inhibitors Epidermis Flavonoids Mice Mitogen-Activated Protein Kinases/antagonists & inhibitors,metabolism Morpholines Nickel/toxicity Phosphatidylinositol 3-Kinases/metabolism Phosphoinositide-3 Kinase Inhibitors Time Factors Vascular Endothelial Growth Factor A/biosynthesis,metabolism
Chemicals
Chelating Agents Chromones Enzyme Inhibitors Flavonoids Morpholines Phosphoinositide-3 Kinase Inhibitors Vascular Endothelial Growth Factor A 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one Egtazic Acid nickel chloride Nickel Mitogen-Activated Protein Kinases nickel sulfide 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one nickel subsulfide
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Ouyang Weiming
Nelson Institute of Environmental Medicine, School of Medicine, New York University, Tuxedo, New York 10987,USA.
Li Jingxia
Shi Xianglin
Costa Max
Huang Chuanshu
References (39)
39 references, click to expand
  1. Vascular endothelial growth factor and vascular adjustments to perturbations in oxygen homeostasis.
    Am J Physiol Cell Physiol. 2001 Jun;280(6):C1367-74 PMID: 11350731
  2. Cap43, a novel gene specifically induced by Ni2+ compounds.
    Cancer Res. 1998 May 15;58(10):2182-9 PMID: 9605764
  3. p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts.
    J Biol Chem. 1998 Jul 17;273(29):18165-72 PMID: 9660776
  4. Evidence against a major role for Ca2+ in hypoxia-induced gene expression in human hepatoma cells (Hep3B).
    J Physiol. 1999 Jun 15;517 ( Pt 3):651-7 PMID: 10358107
  5. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells.
    J Biol Chem. 1995 Dec 29;270(52):31189-95 PMID: 8537383
  6. Depletion of [Ca2+]i inhibits hypoxia-induced vascular permeability factor (vascular endothelial growth factor) gene expression.
    Biochem Biophys Res Commun. 1996 Dec 24;229(3):733-8 PMID: 8954965
  7. The cellular and molecular basis of store-operated calcium entry.
    Nat Cell Biol. 2002 Nov;4(11):E263-72 PMID: 12415286
  8. Carcinogenic nickel induces genes involved with hypoxic stress.
    Cancer Res. 2000 Jan 1;60(1):38-41 PMID: 10646848
  9. Role of ERK and calcium in the hypoxia-induced activation of HIF-1.
    J Cell Physiol. 2003 Jan;194(1):30-44 PMID: 12447987
  10. Loss of thrombospondin transcriptional activity in nickel-transformed cells.
    Mol Cell Biol. 1994 Jan;14(1):851-8 PMID: 8264652
  11. Requirement for phosphatidylinositol 3-kinase in epidermal growth factor-induced AP-1 transactivation and transformation in JB6 P+ cells.
    Mol Cell Biol. 1996 Nov;16(11):6427-35 PMID: 8887671
  12. Mitogen-activated protein kinase cascades and regulation of gene expression.
    Curr Opin Immunol. 1996 Jun;8(3):402-11 PMID: 8793994
  13. Oncogenes and tumor angiogenesis: differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblasts.
    Cancer Res. 2000 Jan 15;60(2):490-8 PMID: 10667605
  14. The effect of antibody against vascular endothelial growth factor on tumor growth and metastasis.
    J Cancer Res Clin Oncol. 1998;124(11):615-20 PMID: 9860290
  15. The biology of vascular endothelial growth factor.
    Endocr Rev. 1997 Feb;18(1):4-25 PMID: 9034784
  16. The biology of VEGF and its receptors.
    Nat Med. 2003 Jun;9(6):669-76 PMID: 12778165
  17. Nickel compounds act through phosphatidylinositol-3-kinase/Akt-dependent, p70(S6k)-independent pathway to induce hypoxia inducible factor transactivation and Cap43 expression in mouse epidermal Cl41 cells.
    Cancer Res. 2004 Jan 1;64(1):94-101 PMID: 14729612
  18. Activation of MAPKs in human bronchial epithelial cells exposed to metals.
    Am J Physiol. 1998 Sep;275(3 Pt 1):L551-8 PMID: 9728050
  19. Nickel-induced plasminogen activator inhibitor-1 expression inhibits the fibrinolytic activity of human airway epithelial cells.
    Toxicol Appl Pharmacol. 2000 Oct 1;168(1):50-7 PMID: 11000099
  20. Reactive oxygen-induced carcinogenesis causes hypermethylation of p16(Ink4a) and activation of MAP kinase.
    Mol Med. 2002 Jan;8(1):1-8 PMID: 11984000
  21. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.
    Science. 1983 Feb 25;219(4587):983-5 PMID: 6823562
  22. Phosphatidylinositol-3 kinase is necessary for 12-O-tetradecanoylphorbol-13-acetate-induced cell transformation and activated protein 1 activation.
    J Biol Chem. 1997 Feb 14;272(7):4187-94 PMID: 9020132
  23. Nickel carcinogenesis, mutation, epigenetics, or selection.
    Environ Health Perspect. 1999 Sep;107(9):A438-9 PMID: 10464080
  24. Nickel carcinogenesis.
    Mutat Res. 2003 Dec 10;533(1-2):67-97 PMID: 14643413
  25. Vascular permeability factor (VPF, VEGF) in tumor biology.
    Cancer Metastasis Rev. 1993 Sep;12(3-4):303-24 PMID: 8281615
  26. A novel pathway for nickel-induced interleukin-8 expression.
    J Biol Chem. 2002 Jul 5;277(27):24225-31 PMID: 11978798
  27. Vascular endothelial growth factor is a secreted angiogenic mitogen.
    Science. 1989 Dec 8;246(4935):1306-9 PMID: 2479986
  28. Phosphatidylinositol-3 kinase dependent pathways: the role in control of cell growth, survival, and malignant transformation.
    Biochemistry (Mosc). 2000 Jan;65(1):59-67 PMID: 10702641
  29. VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic beta cell carcinogenesis.
    Cancer Cell. 2002 Mar;1(2):193-202 PMID: 12086877
  30. Effect of hypoxia upon intracellular calcium concentration of human endothelial cells.
    J Cell Physiol. 1992 Jul;152(1):215-21 PMID: 1618920
  31. p38 MAP kinase's emerging role as a tumor suppressor.
    Adv Cancer Res. 2004;92:95-118 PMID: 15530558
  32. Molecular mechanisms of nickel carcinogenesis: gene silencing by nickel delivery to the nucleus and gene activation/inactivation by nickel-induced cell signaling.
    J Environ Monit. 2003 Apr;5(2):222-3 PMID: 12729258
  33. Loss of Tsc1 or Tsc2 induces vascular endothelial growth factor production through mammalian target of rapamycin.
    Cancer Res. 2003 Sep 1;63(17):5173-7 PMID: 14500340
  34. Antiangiogenic therapy and tumor progression.
    Cancer Cell. 2004 Jan;5(1):13-7 PMID: 14749122
  35. Overexpression of vascular endothelial growth factor-A165 enhances tumor angiogenesis but not metastasis during beta-cell carcinogenesis.
    Cancer Res. 2002 Jan 15;62(2):603-8 PMID: 11809716
  36. MAPK-regulated transcription: a continuously variable gene switch?
    Nat Rev Mol Cell Biol. 2002 Jan;3(1):30-40 PMID: 11823796
  37. Signal transduction to hypoxia-inducible factor 1.
    Biochem Pharmacol. 2002 Sep;64(5-6):993-8 PMID: 12213597
  38. Depletion of intracellular ascorbate by the carcinogenic metals nickel and cobalt results in the induction of hypoxic stress.
    J Biol Chem. 2004 Sep 24;279(39):40337-44 PMID: 15271983
  39. c-Jun and hypoxia-inducible factor 1 functionally cooperate in hypoxia-induced gene transcription.
    Mol Cell Biol. 2002 Jan;22(1):12-22 PMID: 11739718
Article Info
Journal
Molecular and cellular biochemistry
Abbr.
Mol Cell Biochem
ISSN
0300-8177
Published
2005-11-00
Pages
35-43
Language
English
Region
Netherlands
NLM ID
0364456
Subset
IM
Grants
NCI NIH HHS · CA094964 · United States
NCI NIH HHS · CA103180 · United States
NCI NIH HHS · CA112557 · United States
NIEHS NIH HHS · ES000260 · United States
NIEHS NIH HHS · ES012451 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com